| Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised … C Eng, TW Kim, J Bendell, G Argilés, NC Tebbutt, M Di Bartolomeo, ... The lancet oncology 20 (6), 849-861, 2019 | 465 | 2019 |
| Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial DJ Jonker, L Nott, T Yoshino, S Gill, J Shapiro, A Ohtsu, J Zalcberg, ... The lancet Gastroenterology & hepatology 3 (4), 263-270, 2018 | 154 | 2018 |
| Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease MM Vickers, J Bar, I Gorn-Hondermann, N Yarom, M Daneshmand, ... Clinical & experimental metastasis 29, 123-132, 2012 | 154 | 2012 |
| Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapy MM Vickers, TK Choueiri, M Rogers, A Percy, D Finch, I Zama, T Cheng, ... Urology 76 (2), 430-434, 2010 | 91 | 2010 |
| Comorbidity, age and overall survival in patients with advanced pancreatic cancer–results from NCIC CTG PA. 3: a phase III trial of gemcitabine plus erlotinib or placebo MM Vickers, ED Powell, TR Asmis, DJ Jonker, JF Hilton, CJ O’Callaghan, ... European journal of cancer 48 (10), 1434-1442, 2012 | 82 | 2012 |
| Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic … MM Vickers, H Al-Harbi, TK Choueiri, C Kollmannsberger, S North, ... Clinical Genitourinary Cancer 11 (3), 311-315, 2013 | 79 | 2013 |
| Predictors of pathologic complete response after neoadjuvant treatment for rectal cancer: a multicenter study D Armstrong, S Raissouni, JP Hiller, J Mercer, E Powell, A MacLean, ... Clinical colorectal cancer 14 (4), 291-295, 2015 | 74 | 2015 |
| BRCA mutated pancreatic cancer: A change is coming MN Rosen, RA Goodwin, MM Vickers World journal of gastroenterology 27 (17), 1943, 2021 | 71 | 2021 |
| Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant … S Dudani, H Marginean, PA Tang, JG Monzon, S Raissouni, TR Asmis, ... BMC cancer 19, 1-9, 2019 | 54 | 2019 |
| Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG … MM Vickers, CS Karapetis, D Tu, CJ O'Callaghan, TJ Price, NC Tebbutt, ... Annals of oncology 24 (4), 953-960, 2013 | 54 | 2013 |
| Colonic perforation with intraluminal stents and bevacizumab in advanced colorectal cancer: retrospective case series and literature review A Imbulgoda, A MacLean, J Heine, S Drolet, MM Vickers Canadian Journal of Surgery 58 (3), 167, 2015 | 49 | 2015 |
| Clinical and molecular prognostic factors in renal cell carcinoma: what we know so far PA Tang, MM Vickers, DYC Heng Hematology/Oncology Clinics 25 (4), 871-891, 2011 | 36 | 2011 |
| Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer DM Jiang, S Raissouni, J Mercer, A Kumar, R Goodwin, DY Heng, ... Annals of Oncology 26 (10), 2102-2106, 2015 | 35 | 2015 |
| PROSPECT eligibility and clinical outcomes: results from the Pan-Canadian Rectal Cancer Consortium D Bossé, J Mercer, S Raissouni, K Dennis, R Goodwin, D Jiang, E Powell, ... Clinical colorectal cancer 15 (3), 243-249, 2016 | 31 | 2016 |
| Prognostic and predictive biomarkers in renal cell carcinoma MM Vickers, DYC Heng Targeted oncology 5, 85-94, 2010 | 31 | 2010 |
| Risk and predictors of suicide in colorectal cancer patients: a surveillance, epidemiology, and end results analysis HH Samawi, AA Shaheen, PA Tang, DYC Heng, WY Cheung, MM Vickers Current Oncology 24 (6), 513-517, 2017 | 30 | 2017 |
| One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicity R Yeung, Y McConnell, G Roxin, R Banerjee, GB Urgoiti, AR MacLean, ... Current Oncology 21 (3), 449-456, 2014 | 29 | 2014 |
| EGFR expression variance in paired colorectal cancer primary and metastatic tumors N Yarom, C Marginean, T Moyana, I Gorn-Hondermann, HC Birnboim, ... Cancer biology & therapy 10 (5), 416-421, 2010 | 29 | 2010 |
| Characterization of published errors in high-impact oncology journals A Molckovsky, MM Vickers, P Tang Current Oncology 18 (1), 26-32, 2011 | 28 | 2011 |
| Palmar–Plantar Hyperpigmentation with Capecitabine in Adjuvant Colon Cancer MM Vickers, JC Easaw Journal of gastrointestinal cancer 39, 141-143, 2008 | 25 | 2008 |
